Cancer Research 09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 2955-2961, June 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helfman, D. M.
Right arrow Articles by Kuo, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helfman, D. M.
Right arrow Articles by Kuo, J. F.

Phospholipid-sensitive Ca2+-dependent Protein Phosphorylation System in Various Types of Leukemic Cells from Human Patients and in Human Leukemic Cell Lines HL60 and K562, and Its Inhibition by Alkyl-lysophospholipid1

David M. Helfman2, Katherine C. Barnes, Joseph M. Kinkade, Jr., William R. Vogler, Mamoru Shoji and J. F. Kuo3

Departments of Pharmacology [D. M. H., J. F. K.], Biochemistry [K. C. B., J. M. K.], and Medicine (Hematology and Oncology) [W. R. V., M. S.], Emory University School of Medicine, Atlanta, Georgia 30322

Phospholipid-sensitive Ca2+-dependent protein kinase (PL-Ca-PK), its endogenous substrate proteins, and regulation of the enzyme system by an antitumor agent alkyl-lysophospholipid were investigated in various types of leukemic cells (chronic myelocytic, acute myelocytic, and acute monocytic) from patients and in two cultured human leukemic cell lines (HL60 and K562). Exceedingly high levels of PL-Ca-PK, largely localized in the particulate fraction, were found in all types and lines of leukemic cells; much lower levels of cyclic adenosine 3':5'-monophosphate-dependent protein kinase and cyclic guanosine 3':5'-monophosphate-dependent protein kinase were also found. Although numerous and similar endogenous substrates for PL-Ca-PK were found in all cell types and lines examined, substrates specific for certain leukemic cells appeared to be present. Substrate proteins for calmodulin-sensitive Ca2+-dependent protein kinase, cyclic adenosine 3':5'-monophosphate-dependent protein kinase, and cyclic guanosine 3':5'-monophosphate-dependent protein kinase, in comparison, were much fewer or undetected. The PL-Ca-PK activity and the phosphatidylserine-Ca2+-stimulated phosphorylation of endogenous proteins from leukemic cells were inhibited by alkyl-lysophospholipid, which acted as a competitive inhibitor of the phospholipid cofactor of the enzyme.

The findings suggested that the PL-Ca-PK system is a predominant protein phosphorylation system in leukemic cells and that this enzyme system may represent a site of cytotoxic action of alkyl-lysophospholipid.

1 Supported by NIH Grants HL-15696, NS-17608, CA-22294, CA-23391, RR-5364, T32-AM-07298, and T32-GM-07594; American Cancer Society Grant CH-208; and Atlanta Carnival for Cure, Inc., funds for leukemia research.

2 Present address: Cold Spring Harbor Laboratory, Cold Spring Harbor, N. Y. 11724.

3 To whom requests for reprints should be addressed.

Received 10/20/82. Accepted 2/28/83.




This article has been cited by other articles:


Home page
BloodHome page
O. Cuvillier, E. Mayhew, A. S. Janoff, and S. Spiegel
Liposomal ET-18-OCH3 Induces Cytochrome c-Mediated Apoptosis Independently of CD95 (APO-1/Fas) Signaling
Blood, November 15, 1999; 94(10): 3583 - 3592.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. P. Whitman, F. Civoli, and L. W. Daniel
Protein Kinase Cbeta II Activation by 1-beta -D-Arabinofuranosylcytosine Is Antagonistic to Stimulation of Apoptosis and Bcl-2alpha Down-regulation
J. Biol. Chem., September 19, 1997; 272(38): 23481 - 23484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Noland , Jr., X. Guo, R. L. Raynor, N. M. Jideama, V. Averyhart-Fullard, R. J. Solaro, and J. F. Kuo
Cardiac Troponin I Mutants
J. Biol. Chem., October 27, 1995; 270(43): 25445 - 25454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.